Pierre Michetti

16.3k total citations · 3 hit papers
187 papers, 10.9k citations indexed

About

Pierre Michetti is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Pierre Michetti has authored 187 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Genetics, 92 papers in Surgery and 85 papers in Epidemiology. Recurrent topics in Pierre Michetti's work include Inflammatory Bowel Disease (101 papers), Microscopic Colitis (73 papers) and Helicobacter pylori-related gastroenterology studies (48 papers). Pierre Michetti is often cited by papers focused on Inflammatory Bowel Disease (101 papers), Microscopic Colitis (73 papers) and Helicobacter pylori-related gastroenterology studies (48 papers). Pierre Michetti collaborates with scholars based in Switzerland, United States and France. Pierre Michetti's co-authors include Sebastian Suerbaum, Christian Felley, Marian R. Neutra, Valérie Pittet, Richard J. Farrell, Pascal Juillerat, A. L. Blum, Mark A. Peppercorn, Christian Mottet and Mazen Alsahli and has published in prestigious journals such as New England Journal of Medicine, Cell and Nature Medicine.

In The Last Decade

Pierre Michetti

179 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Helicobacter pyloriInfection

2002 2.3k citations Pierre Michetti et al. profile →
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

2010 1.1k citations Gert Van Assche, Pierre Michetti et al. Journal of Crohn s and Colitis profile →
Microbial network disturbances in relapsing refractory Crohn’s disease

2019 295 citations Pascal Juillerat, Nicolas Fournier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Michetti Switzerland	43	5.2k	3.9k	3.2k	3.2k	1.4k	187	10.9k
Arie van der Ende Netherlands	59	2.7k 0.5×	917 0.2×	5.2k 1.6×	1.5k 0.5×	1.9k 1.4×	316	11.3k
Erkki Savilahti Finland	65	3.8k 0.7×	5.0k 1.3×	3.6k 1.1×	1.9k 0.6×	2.2k 1.6×	300	14.6k
Phillip D. Smith United States	52	2.7k 0.5×	788 0.2×	1.9k 0.6×	4.0k 1.3×	1.8k 1.3×	181	10.4k
Jeremy Sanderson United Kingdom	48	1.5k 0.3×	3.5k 0.9×	2.8k 0.9×	1.2k 0.4×	2.3k 1.7×	207	8.5k
R Modigliani France	45	4.1k 0.8×	7.8k 2.0×	5.9k 1.8×	3.0k 1.0×	1.6k 1.2×	161	13.2k
Colm O’Morain Ireland	57	14.3k 2.8×	6.4k 1.7×	4.9k 1.5×	4.2k 1.3×	2.4k 1.7×	272	22.6k
Seymour Katz United States	51	1.8k 0.3×	3.0k 0.8×	2.5k 0.8×	4.1k 1.3×	1.3k 1.0×	248	11.0k
Mathias Chamaillard France	43	2.7k 0.5×	4.9k 1.3×	3.5k 1.1×	8.3k 2.6×	6.3k 4.6×	116	17.2k
Paul Rutgeerts Belgium	44	3.7k 0.7×	5.7k 1.5×	4.1k 1.3×	1.8k 0.6×	2.4k 1.8×	290	10.5k
Lloyd Mayer United States	64	4.0k 0.8×	9.4k 2.4×	6.8k 2.1×	7.7k 2.4×	2.3k 1.7×	184	19.1k

Countries citing papers authored by Pierre Michetti

Since Specialization

Citations

This map shows the geographic impact of Pierre Michetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Michetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Michetti more than expected).

Fields of papers citing papers by Pierre Michetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Michetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Michetti. The network helps show where Pierre Michetti may publish in the future.

Co-authorship network of co-authors of Pierre Michetti

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Michetti. A scholar is included among the top collaborators of Pierre Michetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Michetti. Pierre Michetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Juillerat, Pascal, et al.. (2024). P1162 Upadacitinib in Crohn’s Disease Patients: for what type of patients in real world setting ?. Journal of Crohn s and Colitis. 18(Supplement_1). i2059–i2059.

Juillerat, Pascal, et al.. (2022). Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom?. SHILAP Revista de lepidopterología. 3. 100104–100104. 23 indexed citations

Juillerat, Pascal, Luc Biedermann, Pierre Michetti, et al.. (2020). Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements. United European Gastroenterology Journal. 9(3). 398–406. 10 indexed citations

Pittet, Valérie, et al.. (2018). Patient-reported healthcare expectations in inflammatory bowel diseases. PLoS ONE. 13(5). e0197351–e0197351. 16 indexed citations

Pittet, Valérie, et al.. (2017). Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator. PLoS ONE. 12(2). e0171864–e0171864. 21 indexed citations

Vavricka, Stephan R., Gerhard Rogler, Muriel Spoerri, et al.. (2015). Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflammatory Bowel Diseases. 21(8). 1794–1800. 188 indexed citations

Vavricka, Stephan R., Christine N. Manser, Pascal Frei, et al.. (2014). Addressing current treatment challenges in Crohn's disease in real life: A physician's survey. Digestive and Liver Disease. 46(12). 1066–1071. 3 indexed citations

Reinisch, Walter, Gert Van Assche, Ragnar Befrits, et al.. (2012). Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus. Journal of Crohn s and Colitis. 6(2). 248–258. 32 indexed citations

Pittet, Valérie, Gerhard Rogler, Pierre Michetti, et al.. (2012). Mo1003 Medical Treatments and Risk Factors for Resection Surgery in Crohn's Disease: Results From the Swiss IBD Cohort Study. Gastroenterology. 142(5). S–569.

10.

Roduit, Jocelyn, et al.. (2010). Pullulation [b]bactérienne[/b] de l’intestin grêle. Revue Médicale Suisse. 6(233). 186–191. 1 indexed citations

11.

Schoepfer, Alain, Stephan R. Vavricka, Janek Binek, et al.. (2009). Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population. Inflammatory Bowel Diseases. 16(6). 933–938. 22 indexed citations

12.

Maillard, Michel H., Vinícius Cotta‐de‐Almeida, Fuminao Takeshima, et al.. (2007). The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. The Journal of Experimental Medicine. 204(2). 381–391. 150 indexed citations

13.

Maillard, Michel H., et al.. (2006). Maladies inflammatoires cryptogéniques de l’intestin de novo après transplantation hépatique. Gastroentérologie Clinique et Biologique. 30(8-9). 1096–1101. 3 indexed citations

14.

Beglinger, Christoph, et al.. (2006). Wirksamkeit und Kosten einer kontinuierlichen Langzeitbehandlung mit Esomeprazol versus einer Anwendung bei Bedarf bei symptomatischen Reflux-Patienten in der Praxis ohne endoskopische Abklärung – die ONE Studie (On-demand Nexium® Evaluation). Praxis. 95(13). 483–487. 2 indexed citations

15.

Michetti, Pierre, Christian Mottet, Pascal Juillerat, et al.. (2005). Severe and Steroid-Resistant Crohn’s Disease. Digestion. 71(1). 19–25. 17 indexed citations

16.

Felley, Christian, Brigitte Pignatelli, Jean E. Crabtree, et al.. (2002). Oxidative Stress in Gastric Mucosa of Asymptomatic Humans Infected with Helicobacter pylori: Effect of Bacterial Eradication. Helicobacter. 7(6). 342–348. 28 indexed citations

17.

Felley, Christian, et al.. (2002). Les maladies inflammatoires chroniques de l’intestin. Revue Médicale Suisse. -2(2377). 229–238.

18.

Felley, Christian, Irène Corthésy–Theulaz, P. Sipponen, et al.. (2001). Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. European Journal of Gastroenterology & Hepatology. 13(1). 25–29. 155 indexed citations

19.

Michetti, Pierre. (1997). Vaccine against Helicobacter pylori : fact or fiction?. Gut. 41(6). 728–730. 32 indexed citations

20.

Michetti, Pierre, Gian Dorta, Didier Brassard, et al.. (1995). L. acidophilus supernantant as an adjuvant in the therapy of H. pylori in humans. Gastroenterology. 108(4). A166–A166. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact